1308. Activity of Cefiderocol and Comparators against Gram-negative Isolates from US Patients Hospitalized with Pneumonia

BACKGROUND: Cefiderocol (CFDC) is a novel siderophore-conjugated cephalosporin with broad activity against Gram-negative (GN) bacteria, including carbapenem-resistant isolates, and non-fermentative organisms. CFDC is approved by the FDA for complicated urinary tract infection (cUTI), hospital-acquir...

Descripción completa

Detalles Bibliográficos
Autores principales: Shortridge, Dee, Streit, Jennifer M, Duncan, Leonard R, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644694/
http://dx.doi.org/10.1093/ofid/ofab466.1500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644694/
http://dx.doi.org/10.1093/ofid/ofab466.1500

Ejemplares similares